文献速递姑息放疗与转移瘤放疗物理与技术

非脊柱骨转移立体定向体部放疗后的局部控制与骨折风险

Local control and fracture risk following stereotactic body radiation therapy for non-spine bone metastases.
PubMed 文献 · Radiother Oncol · 2018-04-26

回顾性分析2011至2014年81例患者共106处非脊柱骨转移接受立体定向体部放疗,24个月局部复发累积发生率为13.3%,影像学骨折发生率为8.5%,PTV体积与局部复发显著相关(p=0.02),作者认为该治疗局部控制率高且骨折风险低。

要点

  • 106处非脊柱骨转移行SBRT后24个月局部复发累积发生率为13.3%。
  • PTV体积较大与局部复发显著相关(p=0.02)。
  • 影像学骨折发生率为8.5%(9/106),溶骨性病变(p=0.11)和女性(p=0.09)仅呈趋势。

核心结论

  • 作者认为本研究结果证实SBRT对非脊柱骨转移可获得较高的长期局部控制率且骨折风险低。

研究设计与样本

  • 回顾性分析2011年至2014年接受SBRT的81例患者共106处非脊柱骨转移。

主要发现

  • 中位随访13个月(范围0.25-45.6),患者中位年龄66.4岁(范围36-86),男性占60.5%,前列腺癌为最主要病理类型(32%)。
  • 骨转移最常位于骨盆(41.5%),近半数病灶为硬化性;最常见处方为30 Gy/5次(30.2%)和35 Gy/5次(42.5%)。
  • 6、18和24个月局部复发累积发生率分别为4.7%、8.3%和13.3%,局部复发平均时间11.8个月(范围3.9-23.4)。
  • 局部复发与PTV体积存在显著关联(p=0.02),PTV较大者局部失败风险更高。
  • 治疗体积内影像学骨折发生率为8.5%(9/106),骨折平均时间8.4个月(范围0.7-32.5个月)。

关键数值与推荐

  • 局部复发与PTV体积显著相关(p=0.02)。
  • 溶骨性病变(p=0.11)和女性性别(p=0.09)与骨折仅呈趋势性关联。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: To report local control and toxicity rates for patients treated with stereotactic body radiotherapy (SBRT) for non-spine bone metastases. METHODS AND MATERIALS: Eighty-one patients with 106 non-spine bone metastases were treated between 2011 and 2014 and retrospectively reviewed. Indications included: oligometastases (63%), oligoprogression (17.3%), retreatment (2.4%) or other (17.3%). Cumulative incidence function was used to assess local recurrence and fracture probability. Bivariate relationships were investigated based on selected patient, tumour and dose-volume factors. RESULTS: Mean follow-up was 13 months (range, 0.25-45.6) and the median patient age was 66.4 years (range, 36-86). Most patients were male (60.5%) and the predominant histology prostate cancer (32%). Bone metastases were most commonly located in the pelvis (41.5%) and almost half sclerotic. The most common prescriptions were 30 Gy/5 (30.2%) and 35 Gy/5 (42.5%). The cumulative incidence of local recurrence at 6,18 and 24 months respectively was 4.7%, 8.3% and 13.3% with a mean time to local recurrence of 11.8 months (range, 3.9-23.4). A significant association was found between local recurrence and volume of the PTV (p = 0.02), with larger PTVs having a greater risk of local failure. Fracture was observed radiographically in the treatment volume in 9/106 (8.5%) of treated lesions and the mean time to fracture was 8.4 months (range, 0.7-32.5 months). With respect to predictors, a trend was observed for lytic lesions (p = 0.11) and female gender (p = 0.09). CONCLUSIONS: The results of this study confirm that SBRT yields high rates of long-term local control for non-spine bone metastases with a low fracture risk.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Erler D, Brotherston D, Sahgal A, et al. Local control and fracture risk following stereotactic body radiation therapy for non-spine bone metastases. Radiother Oncol. 2018. PMID: 29706460. doi:10.1016/j.radonc.2018.03.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。